489 related articles for article (PubMed ID: 15229798)
1. Congenital myasthenic syndromes.
Harper CM
Semin Neurol; 2004 Mar; 24(1):111-23. PubMed ID: 15229798
[TBL] [Abstract][Full Text] [Related]
2. Congenital endplate acetylcholinesterase deficiency responsive to ephedrine.
Bestue-Cardiel M; Sáenz de Cabezón-Alvarez A; Capablo-Liesa JL; López-Pisón J; Peña-Segura JL; Martin-Martinez J; Engel AG
Neurology; 2005 Jul; 65(1):144-6. PubMed ID: 16009904
[TBL] [Abstract][Full Text] [Related]
3. [Molecular bases and therapeutic strategies in defective neuromuscular transmissions: lessons learned from a prototypical synapse].
Ohno K; Ito M; Masuda A
Nihon Shinkei Seishin Yakurigaku Zasshi; 2009 Aug; 29(4):145-51. PubMed ID: 19764481
[TBL] [Abstract][Full Text] [Related]
4. Congenital myasthenic syndrome: a brief review.
Lorenzoni PJ; Scola RH; Kay CS; Werneck LC
Pediatr Neurol; 2012 Mar; 46(3):141-8. PubMed ID: 22353287
[TBL] [Abstract][Full Text] [Related]
5. [Congenital diseases of neuromuscular transmission: congenital myasthenia syndromes].
Sieb JP
Nervenarzt; 1995 Feb; 66(2):105-10. PubMed ID: 7715748
[TBL] [Abstract][Full Text] [Related]
6. Clinical and molecular genetic findings in COLQ-mutant congenital myasthenic syndromes.
Mihaylova V; Müller JS; Vilchez JJ; Salih MA; Kabiraj MM; D'Amico A; Bertini E; Wölfle J; Schreiner F; Kurlemann G; Rasic VM; Siskova D; Colomer J; Herczegfalvi A; Fabriciova K; Weschke B; Scola R; Hoellen F; Schara U; Abicht A; Lochmüller H
Brain; 2008 Mar; 131(Pt 3):747-59. PubMed ID: 18180250
[TBL] [Abstract][Full Text] [Related]
7. Sleuthing molecular targets for neurological diseases at the neuromuscular junction.
Engel AG; Ohno K; Sine SM
Nat Rev Neurosci; 2003 May; 4(5):339-52. PubMed ID: 12728262
[No Abstract] [Full Text] [Related]
8. Current understanding of congenital myasthenic syndromes.
Engel AG; Sine SM
Curr Opin Pharmacol; 2005 Jun; 5(3):308-21. PubMed ID: 15907919
[TBL] [Abstract][Full Text] [Related]
9. Congenital myasthenic syndromes: spotlight on genetic defects of neuromuscular transmission.
Müller JS; Mihaylova V; Abicht A; Lochmüller H
Expert Rev Mol Med; 2007 Aug; 9(22):1-20. PubMed ID: 17686188
[TBL] [Abstract][Full Text] [Related]
10. [Congenital myasthenic syndrome (CMS) caused by pre- and post synaptic defects].
Kodama T; Sonoda Y
Ryoikibetsu Shokogun Shirizu; 2001; (36):362-4. PubMed ID: 11596411
[No Abstract] [Full Text] [Related]
11. [Congenital myasthenic syndromes: phenotypic expression and pathophysiological characterisation].
Andreux F; Hantaï D; Eymard B
Rev Neurol (Paris); 2004 Feb; 160(2):163-76. PubMed ID: 15034473
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up in patients with congenital myasthenic syndrome due to CHAT mutations.
Schara U; Christen HJ; Durmus H; Hietala M; Krabetz K; Rodolico C; Schreiber G; Topaloglu H; Talim B; Voss W; Pihko H; Abicht A; Müller JS; Lochmüller H
Eur J Paediatr Neurol; 2010 Jul; 14(4):326-33. PubMed ID: 19900826
[TBL] [Abstract][Full Text] [Related]
13. [Neonatal myasthenic syndromes].
Koenigsberger MR; Pascual JM
Rev Neurol; 2002 Jan 1-15; 34(1):47-51. PubMed ID: 11988891
[TBL] [Abstract][Full Text] [Related]
14. Congenital myasthenic syndromes: multiple molecular targets at the neuromuscular junction.
Engel AG; Ohno K; Shen XM; Sine SM
Ann N Y Acad Sci; 2003 Sep; 998():138-60. PubMed ID: 14592871
[TBL] [Abstract][Full Text] [Related]
15. [Genetic defects and disorders at the neuromuscular junction].
Ohno K
Brain Nerve; 2011 Jul; 63(7):669-78. PubMed ID: 21747136
[TBL] [Abstract][Full Text] [Related]
16. A new mouse model for the slow-channel congenital myasthenic syndrome induced by the AChR εL221F mutation.
Chevessier F; Peter C; Mersdorf U; Girard E; Krejci E; McArdle JJ; Witzemann V
Neurobiol Dis; 2012 Mar; 45(3):851-61. PubMed ID: 22178625
[TBL] [Abstract][Full Text] [Related]
17. Novel congenital myasthenic syndromes associated with defects in quantal release.
Milone M; Fukuda T; Shen XM; Tsujino A; Brengman J; Engel AG
Neurology; 2006 Apr; 66(8):1223-9. PubMed ID: 16525123
[TBL] [Abstract][Full Text] [Related]
18. [Congenital myasthenic syndromes. Clinical and electromyographic evaluation].
Martin Santidrian MA; Prats Viñas JM; Garaizar Axpe C; Ruiz Espinosa C
An Esp Pediatr; 2002 Jan; 56(1):10-6. PubMed ID: 11792263
[TBL] [Abstract][Full Text] [Related]
19. Genes at the junction--candidates for congenital myasthenic syndromes.
Vincent A; Newland C; Croxen R; Beeson D
Trends Neurosci; 1997 Jan; 20(1):15-22. PubMed ID: 9004414
[TBL] [Abstract][Full Text] [Related]
20. [Neurophysiological testing in myasthenia syndromes].
Kostera-Pruszczyk A; Rowińska-Marcińska K; Emeryk-Szajewska B
Neurol Neurochir Pol; 2003; 37(1):161-72. PubMed ID: 12910838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
